Fortis Healthcare (FORTIS) Q4 06/07 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 06/07 earnings summary
30 Oct, 2026Executive summary
FY07 consolidated total income rose 77% YoY to Rs 525.40 crore; net loss attributable to shareholders was Rs 98.12 crore, versus Rs 48.94 crore in FY06.
Standalone total income increased 33% to Rs 132.81 crore, while net loss widened to Rs 48.69 crore from Rs 27.95 crore.
Financial highlights
Consolidated operating profit before finance costs, depreciation and amortisation rose 122% to Rs 61.52 crore; operating margin improved 2.39 percentage points YoY.
Consolidated loss before tax and prior-period items was Rs 88.29 crore; reported EPS was -Rs 5.73 versus -Rs 5.76 in FY06.
Standalone operating profit before finance costs, depreciation and amortisation increased 57% to Rs 13.86 crore; loss before tax and prior-period items reached Rs 46.36 crore.
Consolidated financial expenses were Rs 66.00 crore and goodwill amortisation was Rs 45.53 crore, weighing on reported results.
Outlook and guidance
Healthcare demand was expected to grow strongly given the supply shortfall; the hospital network was positioned to address rising demand for high-end care.
Navi Mumbai hospital IPD services were expected to begin in Q1 or Q2 FY08, with a further Rs 35 crore of capital expenditure estimated to launch operations.
Plans included standardising hospital operating processes, strengthening procurement and optimising capital expenditure to improve scalability and project viability.
Latest events from Fortis Healthcare
- Revenue grew 17.3%, while drug-price controls clouded the margin outlook.FORTIS
Q2 26/27 - Revenue rose and losses narrowed amid expansion, legal and execution risks.FORTIS
Q4 07/08 - First annual profit, stronger margins and expansion toward 40 hospitals by 2012.FORTIS
Q4 08/09 - Revenue grew 49%, Wockhardt expanded the network, and Parkway was exited.FORTIS
Q4 09/10 - International expansion doubled revenue, but FY13 focus shifted to integration and profitability.FORTIS
Q4 11/12 - Revenue grew 58%, with Parkway gains boosting reported profit and expansion driving the next phase.FORTIS
Q4 10/11 - RHT listing lowered leverage as growth strategy pivoted to India and asset-light expansion.FORTIS
Q4 12/13 - India-focused growth and asset sales cut leverage, but continuing operations remained loss-making.FORTIS
Q4 13/14 - India growth lifted margins, but consolidated losses and legal overhangs persisted.FORTIS
Q4 14/15